Regenxbio (RGNX) Other Non Operating Income (2014 - 2025)

Regenxbio's Other Non Operating Income history runs 11 years deep, the most recent figure standing at $18000.0 for Q4 2025.

• In Q4 2025, Other Non Operating Income fell 78.31% year-over-year to $18000.0; the TTM figure through Dec 2025 stood at $83000.0 (down 52.3% YoY), while the FY2025 annual figure was $83000.0, down 52.3% from the prior year.
• Other Non Operating Income was $18000.0 for Q4 2025 at Regenxbio, down from $19000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $554000.0 in Q2 2021 to a low of -$141000.0 in Q4 2023.
• Historically, Other Non Operating Income has averaged $67150.0 across 5 years, with a median of $33000.0 in 2021.
• The sharpest annual moves came in 2022 and 2023: Other Non Operating Income jumped 305.26% in 2022, then plunged 283.12% in 2023.
• A 5-year view of Other Non Operating Income shows it stood at $19000.0 in 2021, then soared by 305.26% to $77000.0 in 2022, then slumped by 283.12% to -$141000.0 in 2023, then jumped by 158.87% to $83000.0 in 2024, then slumped by 78.31% to $18000.0 in 2025.
• The last three Other Non Operating Income figures came in at $18000.0 (Q4 2025), $19000.0 (Q3 2025), and $21000.0 (Q2 2025), per Business Quant data.